The role of caveolin-1 in human breast cancer

Breast Cancer Research and Treatment

Volumn 131, Issue 1, 2012, Pages 1-15

  Patani, Neill ^a,b   Martin, Lesley Ann ^a   Reis Filho, Jorge S ^a   Dowsett, Mitch ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Caveolin 1; Evidence; Oncogene; Tumour suppressor gene

Indexed keywords

CAVEOLIN 1; CHLOROQUINE; DASATINIB; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DOWN REGULATION; DRUG EFFICACY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; ONCOGENE; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; CAVEOLAE; CAVEOLIN 1; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; ONCOGENES; SIGNAL TRANSDUCTION;

EID: 84856214850     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1751-4     Document Type: Review

References (135)

1. RG Anderson 1998 The caveolae membrane system Annu Rev Biochem 67 199 225 10.1146/annurev.biochem.67.1.199 9759488 1:CAS:528:DyaK1cXlsFOmsL0%3D (Pubitemid 28411129)
2. KG Rothberg JE Heuser WC Donzell YS Ying Jr. Glenney RG Anderson 1992 Caveolin, a protein component of caveolae membrane coats Cell 68 4 673 682 0092-8674(92)90143-Z[pii] 1739974 1:CAS:528:DyaK38XhvFWnurY%3D
3. B Razani SE Woodman MP Lisanti 2002 Caveolae: from cell biology to animal physiology Pharmacol Rev 54 3 431 467 12223531 1:CAS:528:DC%2BD38XotVSmsrw%3D
4. SE Elsheikh AR Green EA Rakha RM Samaka AA Ammar D Powe JS Reis-Filho IO Ellis 2008 Caveolin 1 and caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype Br J Cancer 99 2 327 334 6604463[pii]10.1038/sj.bjc.6604463 18612310 1:CAS:528:DC%2BD1cXosFWntrY%3D
5. C Jones E Ford C Gillett K Ryder S Merrett JS Reis-Filho LG Fulford A Hanby SR Lakhani 2004 Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes Clin Cancer Res 10 18 Pt 1 5988 5997 10.1158/1078-0432.CCR-03-073110/18/5988[pii] 15447982 1:CAS:528:DC%2BD2cXnvVKqu7o%3D (Pubitemid 39287503)
6. K Savage MB Lambros D Robertson RL Jones C Jones A Mackay M James JL Hornick EM Pereira F Milanezi CD Fletcher FC Schmitt A Ashworth JS Reis-Filho 2007 Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis Clin Cancer Res 13 1 90 101 13/1/90[pii]10.1158/1078-0432.CCR-06-1371 17200343 1:CAS:528:DC%2BD2sXotlel (Pubitemid 46121857)
7. SM Pinilla E Honrado D Hardisson J Benitez J Palacios 2006 Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer Breast Cancer Res Treat 99 1 85 90 10.1007/s10549-006-9184-1 16541313 1:CAS:528:DC%2BD28XnslShsbo%3D (Pubitemid 44168607)
8. JA Engelman XL Zhang MP Lisanti 1998 Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers FEBS Lett 436 3 403 410 S0014-5793(98)01134-X[pii] 9801158 1:CAS:528:DyaK1cXmvFOrtbg%3D (Pubitemid 28482971)
9. JC Zenklusen I Bieche R Lidereau CJ Conti 1994 (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer Proc Natl Acad Sci USA 91 25 12155 12158 7991599 1:CAS:528:DyaK2MXisF2jsrw%3D
10. I Bieche MH Champeme F Matifas K Hacene R Callahan R Lidereau 1992 Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer Lancet 339 8786 139 143 0140-6736(92)90208-K[pii] 1346009 1:STN:280: DyaK387gs12hsQ%3D%3D
11. M Shatz M Liscovitch 2008 Caveolin-1: a tumor-promoting role in human cancer Int J Radiat Biol 84 3 177 189 790900135[pii]10.1080/09553000701745293 18300018 1:CAS:528:DC%2BD1cXitleku7Y%3D (Pubitemid 351323417)
12. MP Lisanti PE Scherer Z Tang M Sargiacomo 1994 Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis Trends Cell Biol 4 7 231 235 0962892494901147[pii] 14731661 1:CAS:528:DyaK2MXjsVyrtQ%3D%3D (Pubitemid 24190653)
13. S Li R Seitz MP Lisanti 1996 Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo J Biol Chem 271 7 3863 3868 8632005 1:CAS:528:DyaK28XhtFOku74%3D
14. KS Song S Li T Okamoto LA Quilliam M Sargiacomo MP Lisanti 1996 Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains J Biol Chem 271 16 9690 9697 8621645 1:CAS:528: DyaK28XisFSls7g%3D
15. J Couet M Sargiacomo MP Lisanti 1997 Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities J Biol Chem 272 48 30429 30438 9374534 1:CAS:528:DyaK2sXnslGgs74%3D (Pubitemid 27512253)
16. JA Engelman RJ Lee A Karnezis DJ Bearss M Webster P Siegel WJ Muller JJ Windle RG Pestell MP Lisanti 1998 Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer J Biol Chem 273 32 20448 20455 9685399 1:CAS:528:DyaK1cXlsVWgtbc%3D (Pubitemid 28377612)
17. M Razandi P Oh A Pedram J Schnitzer ER Levin 2002 ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions Mol Endocrinol 16 1 100 115 11773442 1:CAS:528:DC%2BD38XhvVCiuw%3D%3D (Pubitemid 34044501)
18. S Li T Okamoto M Chun M Sargiacomo JE Casanova SH Hansen I Nishimoto MP Lisanti 1995 Evidence for a regulated interaction between heterotrimeric G proteins and caveolin J Biol Chem 270 26 15693 15701 7797570 1:CAS:528:DyaK2MXmslejsrs%3D
19. G Garcia-Cardena P Martasek BS Masters PM Skidd J Couet S Li MP Lisanti WC Sessa 1997 Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo J Biol Chem 272 41 25437 25440 9325253 1:CAS:528:DyaK2sXms1CqsL0%3D (Pubitemid 27438846)
20. H Ju R Zou VJ Venema RC Venema 1997 Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity J Biol Chem 272 30 18522 18525 9228013 1:CAS:528:DyaK2sXltVSgsrs%3D (Pubitemid 27318186)
21. J Couet S Li T Okamoto T Ikezu MP Lisanti 1997 Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins J Biol Chem 272 10 6525 6533 9045678 1:CAS:528:DyaK2sXhvVOlsro%3D (Pubitemid 27118133)
22. DI Mundy T Machleidt YS Ying RG Anderson GS Bloom 2002 Dual control of caveolar membrane traffic by microtubules and the actin cytoskeleton J Cell Sci 115 Pt 22 4327 4339 12376564 1:CAS:528:DC%2BD38XpsVyjs74%3D (Pubitemid 35460703)
23. L Pelkmans T Burli M Zerial A Helenius 2004 Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic Cell 118 6 767 780 10.1016/j.cell.2004.09.003S0092867404008335[pii] 15369675 1:CAS:528:DC%2BD2cXnvFehtbg%3D (Pubitemid 39221735)
24. PA Orlandi PH Fishman 1998 Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains J Cell Biol 141 4 905 915 9585410 1:CAS:528:DyaK1cXjt1Kgtbk%3D (Pubitemid 28243959)
25. EJ Smart GA Graf MA McNiven WC Sessa JA Engelman PE Scherer T Okamoto MP Lisanti 1999 Caveolins, liquid-ordered domains, and signal transduction Mol Cell Biol 19 11 7289 7304 10523618 1:CAS:528:DyaK1MXmvFeksbw%3D (Pubitemid 29493393)
26. JE Schnitzer J Liu P Oh 1995 Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases J Biol Chem 270 24 14399 14404 7782301 1:CAS:528:DyaK2MXmsVSitrs%3D
27. K Wiechen L Diatchenko A Agoulnik KM Scharff H Schober K Arlt B Zhumabayeva PD Siebert M Dietel R Schafer C Sers 2001 Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene Am J Pathol 159 5 1635 1643 S0002-9440(10)63010-6[pii]10.1016/ S0002-9440(10)63010-6 11696424 1:CAS:528:DC%2BD3MXoslartLs%3D (Pubitemid 33062506)
28. FC Bender MA Reymond C Bron AF Quest 2000 Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity Cancer Res 60 20 5870 5878 11059785 1:CAS:528:DC%2BD3cXnvVSntL4%3D
29. K Wiechen C Sers A Agoulnik K Arlt M Dietel PM Schlag U Schneider 2001 Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas Am J Pathol 158 3 833 839 11238032 1:CAS:528:DC%2BD3MXitlOnur0%3D (Pubitemid 32221776)
30. CC Ho PH Huang HY Huang YH Chen PC Yang SM Hsu 2002 Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation Am J Pathol 161 5 1647 1656 12414512 1:CAS:528:DC%2BD38XptV2gt7s%3D
31. SH Yoo YS Park HR Kim SW Sung JH Kim YS Shim SD Lee YL Choi MK Kim DH Chung 2003 Expression of caveolin-1 is associated with poor prognosis of patients with squamous cell carcinoma of the lung Lung Cancer 42 2 195 202 S0169500203002873[pii] 14568687 (Pubitemid 37268030)
32. K Kato Y Hida M Miyamoto H Hashida T Shinohara T Itoh S Okushiba S Kondo H Katoh 2002 Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage Cancer 94 4 929 933 10.1002/cncr.10329[pii] 11920460 1:CAS:528:DC%2BD38XitVKhs78%3D (Pubitemid 34150846)
33. G Yang LD Truong TM Wheeler TC Thompson 1999 Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker Cancer Res 59 22 5719 5723 10582690 1:CAS:528:DyaK1MXnslyhtbw%3D
34. SW Lee CL Reimer P Oh DB Campbell JE Schnitzer 1998 Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells Oncogene 16 11 1391 1397 10.1038/sj.onc.1201661 9525738 1:CAS:528:DyaK1cXit1Cjtrw%3D (Pubitemid 28151846)
35. G Fiucci D Ravid R Reich M Liscovitch 2002 Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells Oncogene 21 15 2365 2375 10.1038/sj.onc.1205300 11948420 1:CAS:528:DC%2BD38XivFykurY%3D (Pubitemid 34413560)
36. JA Engelman CC Wykoff S Yasuhara KS Song T Okamoto MP Lisanti 1997 Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth J Biol Chem 272 26 16374 16381 9195944 1:CAS:528:DyaK2sXkt1agsL0%3D (Pubitemid 27276462)
37. W Zou L McDaneld LM Smith 2003 Caveolin-1 haploinsufficiency leads to partial transformation of human breast epithelial cells Anticancer Res 23 6C 4581 4586 14981899 1:CAS:528:DC%2BD2cXhvVGgtLk%3D (Pubitemid 38173870)
38. TM Williams MP Lisanti 2005 Caveolin-1 in oncogenic transformation, cancer, and metastasis Am J Physiol Cell Physiol 288 3 C494 C506 288/3/C494[pii]10.1152/ajpcell.00458.2004 15692148 1:CAS:528: DC%2BD2MXisVKrtbg%3D (Pubitemid 40229478)
39. RJ Lee C Albanese M Fu M D'Amico B Lin G Watanabe GK Haines 3rd PM Siegel MC Hung Y Yarden JM Horowitz WJ Muller RG Pestell 2000 Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway Mol Cell Biol 20 2 672 683 10611246 1:CAS:528: DC%2BD3cXjtVKltA%3D%3D (Pubitemid 30023109)
40. A Schlegel P Arvan MP Lisanti 2001 Caveolin-1 binding to endoplasmic reticulum membranes and entry into the regulated secretory pathway are regulated by serine phosphorylation. Protein sorting at the level of the endoplasmic reticulum J Biol Chem 276 6 4398 4408 10.1074/jbc.M005448200M005448200[pii] 11078729 1:CAS:528:DC%2BD3MXht1Gnsbs%3D
41. C Glait D Ravid SW Lee M Liscovitch H Werner 2006 Caveolin-1 controls BRCA1 gene expression and cellular localization in human breast cancer cells FEBS Lett 580 22 5268 5274 S0014-5793(06)01061-1[pii]10.1016/j.febslet.2006.08. 071 16979166 1:CAS:528:DC%2BD28XpvFGntLg%3D (Pubitemid 44415804)
42. Y Wang J Yu Q Zhan 2008 BRCA1 regulates caveolin-1 expression and inhibits cell invasiveness Biochem Biophys Res Commun 370 2 201 206 S0006-291X(08)00459-2[pii]10.1016/j.bbrc.2008.03.031 18343216 1:CAS:528:DC%2BD1cXlslCqsb0%3D
43. A Caselli B Mazzinghi G Camici G Manao G Ramponi 2002 Some protein tyrosine phosphatases target in part to lipid rafts and interact with caveolin-1 Biochem Biophys Res Commun 296 3 692 697 S0006291X02009282[pii] 12176037 1:CAS:528:DC%2BD38XmtFShtbc%3D
44. TM Williams H Lee MW Cheung AW Cohen B Razani P Iyengar PE Scherer RG Pestell MP Lisanti 2004 Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia J Biol Chem 279 23 24745 24756 10.1074/jbc.M402064200M402064200[pii] 15044451 1:CAS:528: DC%2BD2cXksV2iu7w%3D (Pubitemid 38725342)
45. Z Xie X Zeng T Waldman RI Glazer 2003 Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 activates beta-catenin and c-Myc, and down-regulates caveolin-1 Cancer Res 63 17 5370 5375 14500370 1:CAS:528:DC%2BD3sXntlekur0%3D (Pubitemid 37139853)
46. DA Rodriguez JC Tapia JG Fernandez VA Torres N Munoz D Galleguillos L Leyton AF Quest 2009 Caveolin-1-mediated suppression of cyclooxygenase-2 via a beta-catenin-Tcf/Lef-dependent transcriptional mechanism reduced prostaglandin E2 production and survivin expression Mol Biol Cell 20 8 2297 2310 E08-09-0939[pii]10.1091/mbc.E08-09-0939 19244345 1:CAS:528:DC%2BD1MXotVykt7Y%3D
47. F Galbiati D Volonte AM Brown DE Weinstein A Ben-Ze'ev RG Pestell MP Lisanti 2000 Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains J Biol Chem 275 30 23368 23377 10.1074/jbc.M002020200M002020200[pii] 10816572 1:CAS:528: DC%2BD3cXltlGqtb4%3D (Pubitemid 30646240)
48. VA Torres JC Tapia DA Rodriguez A Lladser C Arredondo L Leyton AF Quest 2007 E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef- dependent transcription Mol Cell Biol 27 21 7703 7717 MCB.01991-06[pii]10.1128/ MCB.01991-06 17785436 1:CAS:528:DC%2BD2sXht1Glt7%2FO (Pubitemid 350033675)
49. W Zhang B Razani Y Altschuler B Bouzahzah KE Mostov RG Pestell MP Lisanti 2000 Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). Transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1 J Biol Chem 275 27 20717 20725 10.1074/jbc.M909895199M909895199[pii] 10748172 1:CAS:528:DC%2BD3cXkvVyhtro%3D (Pubitemid 30457660)
50. F Sotgia TM Williams W Schubert F Medina C Minetti RG Pestell MP Lisanti 2006 Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness Am J Pathol 168 1 292 309 168/1/292[pii] 16400031 1:CAS:528:DC%2BD28XhtVKktrs%3D (Pubitemid 43062581)
51. S Le Lay TV Kurzchalia 2005 Getting rid of caveolins: phenotypes of caveolin-deficient animals Biochim Biophys Acta 1746 3 322 333 S0167-4889(05)00103-5[pii]10.1016/j.bbamcr.2005.06.001 16019085 1:CAS:528:DC%2BD2MXhtlCqtLvF (Pubitemid 41815026)
52. H Lee DS Park B Razani RG Russell RG Pestell MP Lisanti 2002 Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia Am J Pathol 161 4 1357 1369 12368209 1:CAS:528:DC%2BD38Xotl2jsLs%3D
53. TM Williams F Sotgia H Lee G Hassan D Di Vizio G Bonuccelli F Capozza I Mercier H Rui RG Pestell MP Lisanti 2006 Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells Am J Pathol 169 5 1784 1801 169/5/1784[pii] 17071600 1:CAS:528:DC%2BD28Xht12isr3N (Pubitemid 351182008)
54. TM Williams F Medina I Badano RB Hazan J Hutchinson WJ Muller NG Chopra PE Scherer RG Pestell MP Lisanti 2004 Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion J Biol Chem 279 49 51630 51646 10.1074/jbc.M409214200M409214200[pii] 15355971 1:CAS:528:DC%2BD2cXhtVaqs7nJ (Pubitemid 40017914)
55. EK Sloan KL Stanley RL Anderson 2004 Caveolin-1 inhibits breast cancer growth and metastasis Oncogene 23 47 7893 7897 10.1038/sj.onc. 12080621208062[pii] 15334058 1:CAS:528:DC%2BD2cXotl2ktbs%3D (Pubitemid 39457039)
56. Y Sagara K Mimori K Yoshinaga F Tanaka K Nishida S Ohno H Inoue M Mori 2004 Clinical significance of caveolin-1, caveolin-2 and HER2/neu mRNA expression in human breast cancer Br J Cancer 91 5 959 965 10.1038/sj.bjc. 66020296602029[pii] 15305200 1:CAS:528:DC%2BD2cXmvFSlu70%3D (Pubitemid 39273791)
57. SS Park JE Kim YA Kim YC Kim SW Kim 2005 Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast Histopathology 47 6 625 630 HIS2303[pii]10.1111/j.1365- 2559.2005.02303.x 16324201 (Pubitemid 41775186)
58. EK Sloan DR Ciocca N Pouliot A Natoli C Restall MA Henderson MA Fanelli FD Cuello-Carrion FE Gago RL Anderson 2009 Stromal cell expression of caveolin-1 predicts outcome in breast cancer Am J Pathol 174 6 2035 2043 ajpath.2009.080924[pii]10.2353/ajpath.2009.080924 19411449 1:CAS:528: DC%2BD1MXmvFOquro%3D
59. G Perrone V Altomare M Zagami S Morini T Petitti C Battista AO Muda C Rabitti 2009 Caveolin-1 expression in human breast lobular cancer progression Mod Pathol 22 1 71 78 modpathol2008154[pii]10.1038/modpathol.2008.154 18836420 1:CAS:528:DC%2BD1MXht1ejuw%3D%3D
60. B Weigelt FC Geyer R Natrajan MA Lopez-Garcia AS Ahmad K Savage B Kreike JS Reis-Filho 2010 The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type J Pathol 220 1 45 57 10.1002/path.2629 19877120 1:CAS:528:DC%2BC3cXpvFOisg%3D%3D
61. C Jones A Mackay A Grigoriadis A Cossu JS Reis-Filho L Fulford T Dexter S Davies K Bulmer E Ford S Parry M Budroni G Palmieri AM Neville MJ O'Hare SR Lakhani 2004 Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer Cancer Res 64 9 3037 3045 15126339 1:CAS:528:DC%2BD2cXjs1ehsbk%3D (Pubitemid 38581402)
62. E Charafe-Jauffret C Ginestier F Monville P Finetti J Adelaide N Cervera S Fekairi L Xerri J Jacquemier D Birnbaum F Bertucci 2006 Gene expression profiling of breast cell lines identifies potential new basal markers Oncogene 25 15 2273 2284 1209254[pii]10.1038/sj.onc.1209254 16288205 1:CAS:528: DC%2BD28XjtFOru7k%3D
63. A Grigoriadis A Mackay JS Reis-Filho D Steele C Iseli BJ Stevenson CV Jongeneel H Valgeirsson K Fenwick M Iravani M Leao AJ Simpson RL Strausberg PS Jat A Ashworth AM Neville MJ O'Hare 2006 Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data Breast Cancer Res 8 5 R56 bcr1604[pii]10.1186/bcr1604 17014703 (Pubitemid 44698287)
64. K Hayashi S Matsuda K Machida T Yamamoto Y Fukuda Y Nimura T Hayakawa M Hamaguchi 2001 Invasion activating caveolin-1 mutation in human scirrhous breast cancers Cancer Res 61 6 2361 2364 11289096 1:CAS:528:DC%2BD3MXisVSltbs%3D (Pubitemid 32685805)
65. T Li F Sotgia MA Vuolo M Li WC Yang RG Pestell JA Sparano MP Lisanti 2006 Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status Am J Pathol 168 6 1998 2013 168/6/1998[pii] 16723714 1:CAS:528:DC%2BD28XlvVOhsb0%3D (Pubitemid 43825319)
66. N Syeed SA Husain S Abdullah AS Sameer NA Chowdri MS Nanda MA Siddiqi 2010 Caveolin-1 promotes mammary tumorigenesis: mutational profile of the Kashmiri population Asian Pac J Cancer Prev 11 3 689 696 21039037
67. ST Chen SY Lin KT Yeh SJ Kuo WL Chan YP Chu JG Chang 2004 Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers Int J Mol Med 14 4 577 582 15375584 1:CAS:528:DC%2BD2cXovFWnt7w%3D
68. S Koike Y Kodera A Nakao H Iwata Y Yatabe 2010 Absence of the caveolin-1 P132L mutation in cancers of the breast and other organs J Mol Diagn 12 5 712 717 jmoldx.2010.090180[pii]10.2353/jmoldx.2010.090180 20581046 1:CAS:528:DC%2BC3cXht1eqsrrP
69. M Lacroix-Triki FC Geyer JS Reis-Filho 2010 Caveolin-1 P132L mutation in human cancers: 1 CAVeat to be voiced J Mol Diagn 12 5 562 565 jmoldx.2010.100093[pii]10.2353/jmoldx.2010.100093 20581045 1:CAS:528: DC%2BC3cXht1eqsr7J
70. AF Hurlstone G Reid Jr. Reeves J Fraser G Strathdee M Rahilly EK Parkinson DM Black 1999 Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines Oncogene 18 10 1881 1890 10.1038/sj.onc.1202491 10086342 1:CAS:528:DyaK1MXit1ertb4%3D (Pubitemid 29145855)
71. P Wu B Qi H Zhu Y Zheng F Li J Chen 2007 Suppression of staurosporine-mediated apoptosis in Hs578T breast cells through inhibition of neutral-sphingomyelinase by caveolin-1 Cancer Lett 256 1 64 72 S0304-3835(07)00234-0[pii]10.1016/j.canlet.2007.05.007 17618736 1:CAS:528:DC%2BD2sXpvFGrtbg%3D (Pubitemid 47333326)
72. D Ravid S Maor H Werner M Liscovitch 2005 Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling Oncogene 24 8 1338 1347 1208337[pii]10.1038/sj.onc.1208337 15592498 1:CAS:528:DC%2BD2MXhtlOrsrY%3D (Pubitemid 40343114)
73. DA Zajchowski MF Bartholdi Y Gong L Webster HL Liu A Munishkin C Beauheim S Harvey SP Ethier PH Johnson 2001 Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells Cancer Res 61 13 5168 5178 11431356 1:CAS:528:DC%2BD3MXltVCjsr0%3D (Pubitemid 32681550)
74. H Yamaguchi Y Takeo S Yoshida Z Kouchi Y Nakamura K Fukami 2009 Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells Cancer Res 69 22 8594 8602 0008-5472.CAN-09-2305[pii]10.1158/0008-5472.CAN-09-2305 19887621 1:CAS:528:DC%2BD1MXhtl2rsbbJ
75. B Joshi SS Strugnell JG Goetz LD Kojic ME Cox OL Griffith SK Chan SJ Jones SP Leung H Masoudi S Leung SM Wiseman IR Nabi 2008 Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion Cancer Res 68 20 8210 8220 68/20/8210[pii]10.1158/0008- 5472.CAN-08-0343 18922892 1:CAS:528:DC%2BD1cXht1Cmsb%2FE
76. A Nestl OD Von Stein K Zatloukal WG Thies P Herrlich M Hofmann JP Sleeman 2001 Gene expression patterns associated with the metastatic phenotype in rodent and human tumors Cancer Res 61 4 1569 1577 11245467 1:CAS:528: DC%2BD3MXhvVeltbk%3D (Pubitemid 34292589)
77. Y Lavie G Fiucci M Liscovitch 1998 Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells J Biol Chem 273 49 32380 32383 9829965 1:CAS:528:DyaK1cXnvFOnsLc%3D (Pubitemid 28557607)
78. Y Lavie G Fiucci M Liscovitch 2001 Upregulation of caveolin in multidrug resistant cancer cells: functional implications Adv Drug Deliv Rev 49 3 317 323 S0169409X01001442[pii] 11551402 1:CAS:528:DC%2BD3MXlsF2js74%3D (Pubitemid 32718691)
79. CH Storch R Ehehalt WE Haefeli J Weiss 2007 Localization of the human breast cancer resistance protein (BCRP/ABCG2) in lipid rafts/caveolae and modulation of its activity by cholesterol in vitro J Pharmacol Exp Ther 323 1 257 264 jpet.107.122994[pii]10.1124/jpet.107.122994 17652262 1:CAS:528:DC%2BD2sXhtFahsb7O (Pubitemid 47443266)
80. H Zhu C Cai J Chen 2004 Suppression of P-glycoprotein gene expression in Hs578T/Dox by the overexpression of caveolin-1 FEBS Lett 576 3 369 374 S0014579304011573[pii]10.1016/j.febslet.2004.09.041 15498565 1:CAS:528:DC%2BD2cXovV2itL8%3D (Pubitemid 39388630)
81. A Dasari JN Bartholomew D Volonte F Galbiati 2006 Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements Cancer Res 66 22 10805 10814 66/22/10805[pii]10.1158/ 0008-5472.CAN-06-1236 17108117 1:CAS:528:DC%2BD2sXivVyqsb4%3D (Pubitemid 44876976)
82. J Li GS Hassan TM Williams C Minetti RG Pestell HB Tanowitz PG Frank F Sotgia MP Lisanti 2005 Loss of caveolin-1 causes the hyper-proliferation of intestinal crypt stem cells, with increased sensitivity to whole body gamma-radiation Cell Cycle 4 12 1817 1825 2199[pii] 16294037 1:CAS:528:DC%2BD28XktVCgsrs%3D (Pubitemid 41827329)
83. C Liedtke C Kersting H Burger L Kiesel P Wulfing 2007 Caveolin-1 expression in benign and malignant lesions of the breast World J Surg Oncol 5 110 1477-7819-5-110[pii]10.1186/1477-7819-5-110 17915016 (Pubitemid 350167996)
84. G Yang LD Truong TL Timme C Ren TM Wheeler SH Park Y Nasu CH Bangma MW Kattan PT Scardino TC Thompson 1998 Elevated expression of caveolin is associated with prostate and breast cancer Clin Cancer Res 4 8 1873 1880 9717814 1:CAS:528:DyaK1cXls1Ghurg%3D (Pubitemid 28369170)
85. S Garcia JP Dales E Charafe-Jauffret S Carpentier-Meunier L Andrac-Meyer J Jacquemier C Andonian MN Lavaut C Allasia P Bonnier C Charpin 2007 Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype Hum Pathol 38 6 830 841 S0046-8177(06)00668-X[pii]10.1016/j.humpath.2006.11.015 17316758 1:CAS:528:DC%2BD2sXlsFKhu7k%3D (Pubitemid 46726507)
86. SY Han T Druck K Huebner 2003 Candidate tumor suppressor genes at FRA7G are coamplified with MET and do not suppress malignancy in a gastric cancer Genomics 81 2 105 107 S0888754302000290[pii] 12620387 1:CAS:528: DC%2BD3sXhsFOgs7w%3D (Pubitemid 36298601)
87. NN Nupponen L Kakkola P Koivisto T Visakorpi 1998 Genetic alterations in hormone-refractory recurrent prostate carcinomas Am J Pathol 153 1 141 148 S0002-9440(10)65554-X[pii]10.1016/S0002-9440(10)65554-X 9665474 1:CAS:528:DyaK1cXks1GrsLs%3D (Pubitemid 28317516)
88. GG Van den Eynden SJ Van Laere I Van der Auwera SD Merajver EA Van Marck P van Dam PB Vermeulen LY Dirix KL van Golen 2006 Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer Breast Cancer Res Treat 95 3 219 228 10.1007/s10549-005-9002-1 16244790
89. AK Witkiewicz A Dasgupta F Sotgia I Mercier RG Pestell M Sabel CG Kleer Jr. Brody MP Lisanti 2009 An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers Am J Pathol 174 6 2023 2034 ajpath.2009.080873[pii]10.2353/ajpath.2009.080873 19411448 1:CAS:528:DC%2BD1MXmvFOqur0%3D
90. AK Witkiewicz A Dasgupta S Sammons O Er MB Potoczek F Guiles F Sotgia Jr. Brody EP Mitchell MP Lisanti 2010 Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers Cancer Biol Ther 10 2 135 143 11983[pii] 20431349
91. AK Witkiewicz A Dasgupta KH Nguyen C Liu AJ Kovatich GF Schwartz RG Pestell F Sotgia H Rui MP Lisanti 2009 Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer Cancer Biol Ther 8 11 1071 1079 8874[pii] 19502809 1:CAS:528:DC%2BD1MXhtVehsbbE
92. JG Goetz S Minguet I Navarro-Lerida JJ Lazcano R Samaniego E Calvo M Tello T Osteso-Ibanez T Pellinen A Echarri A Cerezo AJ Klein-Szanto R Garcia PJ Keely P Sanchez-Mateos E Cukierman MA Del Pozo 2011 Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis Cell 146 1 148 163 S0092-8674(11)00645-3[pii]10.1016/j.cell.2011.05.040 21729786 1:CAS:528:DC%2BC3MXoslCksrw%3D
93. I Mercier MC Casimiro C Wang AL Rosenberg J Quong A Minkeu KG Allen C Danilo F Sotgia G Bonuccelli JF Jasmin H Xu E Bosco B Aronow A Witkiewicz RG Pestell ES Knudsen MP Lisanti 2008 Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: implications for the response to hormonal therapy Cancer Biol Ther 7 8 1212 1225 6220[pii] 18458534 1:CAS:528:DC%2BD1cXht1GqsrzF
94. UE Martinez-Outschoorn S Pavlides D Whitaker-Menezes KM Daumer JN Milliman B Chiavarina G Migneco AK Witkiewicz MP Martinez-Cantarin N Flomenberg A Howell RG Pestell MP Lisanti F Sotgia 2010 Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: Implications for breast cancer and DCIS therapy with autophagy inhibitors Cell Cycle 9 12 2423 2433 12048[pii] 20562526 1:CAS:528:DC%2BC3cXhtlGmu7bP
95. G Bonuccelli D Whitaker-Menezes R Castello-Cros S Pavlides RG Pestell A Fatatis AK Witkiewicz MG Vander Heiden G Migneco B Chiavarina PG Frank F Capozza N Flomenberg UE Martinez-Outschoorn F Sotgia MP Lisanti 2010 The reverse Warburg effect: Glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts Cell Cycle 9 10 1960 1971 11601[pii] 20495363 1:CAS:528:DC%2BC3cXht12kur7O
96. S Pavlides A Tsirigos I Vera N Flomenberg PG Frank MC Casimiro C Wang RG Pestell UE Martinez-Outschoorn A Howell F Sotgia MP Lisanti 2010 Transcriptional evidence for the "reverse Warburg effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "neuron-glia metabolic coupling" Aging (Albany NY) 2 4 185 199 v2/n4/full/100134.html[pii] 1:CAS:528: DC%2BC3cXmtlahs7g%3D
97. JN Bartholomew D Volonte F Galbiati 2009 Caveolin-1 regulates the antagonistic pleiotropic properties of cellular senescence through a novel Mdm2/p53-mediated pathway Cancer Res 69 7 2878 2886 0008-5472.CAN-08-2857[pii] 10.1158/0008-5472.CAN-08-2857 19318577 1:CAS:528:DC%2BD1MXjvVWis7g%3D
98. C Sotiriou L Pusztai 2009 Gene-expression signatures in breast cancer N Engl J Med 360 8 790 800 360/8/790[pii]10.1056/NEJMra0801289 19228622 1:CAS:528:DC%2BD1MXitFWqs70%3D
99. B Weigelt FL Baehner JS Reis-Filho 2010 The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade J Pathol 220 2 263 280 10.1002/path.2648 19927298 1:CAS:528:DC%2BC3cXht1Ontrg%3D
100. C Desmedt B Haibe-Kains P Wirapati M Buyse D Larsimont G Bontempi M Delorenzi M Piccart C Sotiriou 2008 Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes Clin Cancer Res 14 16 5158 5165 14/16/5158[pii]10.1158/1078-0432.CCR-07-4756 18698033 1:CAS:528:DC%2BD1cXpslKgur4%3D
101. T Iwamoto G Bianchini D Booser Y Qi C Coutant CY Shiang L Santarpia J Matsuoka GN Hortobagyi WF Symmans FA Holmes J O'Shaughnessy B Hellerstedt J Pippen F Andre R Simon L Pusztai 2011 Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer J Natl Cancer Inst 103 3 264 272 djq524[pii]10.1093/jnci/djq524 21191116 1:CAS:528:DC%2BC3MXhslWktro%3D
102. E Charafe-Jauffret F Monville F Bertucci B Esterni C Ginestier P Finetti N Cervera J Geneix M Hassanein L Rabayrol H Sobol C Taranger-Charpin L Xerri P Viens D Birnbaum J Jacquemier 2007 Moesin expression is a marker of basal breast carcinomas Int J Cancer 121 8 1779 1785 10.1002/ijc.22923 17594689 1:CAS:528:DC%2BD2sXhtVyktb7P (Pubitemid 47417297)
103. RS Finn J Dering C Ginther CA Wilson P Glaspy N Tchekmedyian DJ Slamon 2007 Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple- negative" breast cancer cell lines growing in vitro Breast Cancer Res Treat 105 3 319 326 10.1007/s10549-006-9463-x 17268817 1:CAS:528:DC%2BD2sXhtFSlsr3N (Pubitemid 47596452)
104. F Huang K Reeves X Han C Fairchild S Platero TW Wong F Lee P Shaw E Clark 2007 Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection Cancer Res 67 5 2226 2238 67/5/2226[pii]10.1158/0008-5472.CAN-06-3633 17332353 1:CAS:528: DC%2BD2sXitlSjs7g%3D (Pubitemid 46424242)
105. A Schlegel C Wang BS Katzenellenbogen RG Pestell MP Lisanti 1999 Caveolin-1 potentiates estrogen receptor alpha (ERalpha) signaling. Caveolin-1 drives ligand-independent nuclear translocation and activation of ERalpha J Biol Chem 274 47 33551 33556 10559241 1:CAS:528:DyaK1MXns1ejs7k%3D (Pubitemid 129511665)
106. Z Nawaz DM Lonard AP Dennis CL Smith BW O'Malley 1999 Proteasome-dependent degradation of the human estrogen receptor Proc Natl Acad Sci USA 96 5 1858 1862 10051559 1:CAS:528:DyaK1MXhvVSrtbY%3D (Pubitemid 29117832)
107. X Zhang P Shen M Coleman W Zou BW Loggie LM Smith Z Wang 2005 Caveolin-1 down-regulation activates estrogen receptor alpha expression and leads to 17beta-estradiol-stimulated mammary tumorigenesis Anticancer Res 25 1 369 375 15816560 (Pubitemid 40470132)
108. O Kranenburg I Verlaan WH Moolenaar 2001 Regulating c-Ras function. Cholesterol depletion affects caveolin association, GTP loading, and signaling Curr Biol 11 23 1880 1884 S0960-9822(01)00582-6[pii] 11728312 1:CAS:528:DC%2BD3MXovVCnsL8%3D (Pubitemid 33136529)
109. I Mercier MC Casimiro J Zhou C Wang C Plymire KG Bryant KM Daumer F Sotgia G Bonuccelli AK Witkiewicz J Lin TH Tran J Milliman PG Frank JF Jasmin H Rui RG Pestell MP Lisanti 2009 Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions Am J Pathol 174 4 1172 1190 174/4/1172[pii]10.2353/ajpath.2009.080882 19342371
110. JA Engelman XL Zhang MP Lisanti 1999 Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5′ promoter region of the caveolin-1 gene in human breast cancer cell lines FEBS Lett 448 2-3 221 230 S0014-5793(99)00365-8[pii] 10218480 1:CAS:528:DyaK1MXisV2nsrk%3D (Pubitemid 29168492)
111. KM Coleman CL Smith 2001 Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors Front Biosci 6 D1379 D1391 11578956 1:CAS:528:DC%2BD3MXnsFCgur0%3D
112. MJ Kelly ER Levin 2001 Rapid actions of plasma membrane estrogen receptors Trends Endocrinol Metab 12 4 152 156 S1043-2760(01)00377-0[pii] 11295570 1:CAS:528:DC%2BD3MXisF2ks7w%3D (Pubitemid 33713555)
113. ER Levin 2001 Cell localization, physiology, and nongenomic actions of estrogen receptors J Appl Physiol 91 4 1860 1867 11568173 1:CAS:528: DC%2BD3MXnsFSlsLg%3D (Pubitemid 32900382)
114. M Razandi A Pedram ER Levin 2000 Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer Mol Endocrinol 14 9 1434 1447 10976921 1:CAS:528:DC%2BD3cXmt1Onurc%3D
115. M Razandi G Alton A Pedram S Ghonshani P Webb ER Levin 2003 Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane Mol Cell Biol 23 5 1633 1646 12588983 1:CAS:528:DC%2BD3sXhs1Sgsrg%3D (Pubitemid 36246045)
116. F Acconcia P Ascenzi A Bocedi E Spisni V Tomasi A Trentalance P Visca M Marino 2005 Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol Mol Biol Cell 16 1 231 237 E04-07-0547[pii]10.1091/mbc.E04-07-0547 15496458 1:CAS:528: DC%2BD2MXhvFCjtw%3D%3D (Pubitemid 40028339)
117. A Pedram M Razandi RC Sainson JK Kim CC Hughes ER Levin 2007 A conserved mechanism for steroid receptor translocation to the plasma membrane J Biol Chem 282 31 22278 22288 M611877200[pii]10.1074/jbc.M611877200 17535799 1:CAS:528:DC%2BD2sXot1Squ7s%3D (Pubitemid 47267344)
118. ER Levin 2009 Membrane oestrogen receptor alpha signalling to cell functions J Physiol 587 Pt 21 5019 5023 jphysiol.2009.177097[pii]10.1113/ jphysiol.2009.177097 19687123 1:CAS:528:DC%2BD1MXhsVSktb3N
119. NB Thomas IR Hutcheson L Campbell J Gee KM Taylor RI Nicholson M Gumbleton 2010 Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance Breast Cancer Res Treat 119 3 575 591 10.1007/s10549-009-0355-8 19288272 1:CAS:528:DC%2BC3cXlslWrug%3D%3D
120. Z Lu S Ghosh Z Wang T Hunter 2003 Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion Cancer Cell 4 6 499 515 S1535610803003040[pii] 14706341 1:CAS:528:DC%2BD2cXitFOjtw%3D%3D (Pubitemid 38050046)
121. T Ringerike FD Blystad FO Levy IH Madshus E Stang 2002 Cholesterol is important in control of EGF receptor kinase activity but EGF receptors are not concentrated in caveolae J Cell Sci 115 Pt 6 1331 1340 11884532 1:CAS:528:DC%2BD38XivFGnt7g%3D (Pubitemid 34272497)
122. YN Kim GJ Wiepz AG Guadarrama PJ Bertics 2000 Epidermal growth factor-stimulated tyrosine phosphorylation of caveolin-1. Enhanced caveolin-1 tyrosine phosphorylation following aberrant epidermal growth factor receptor status J Biol Chem 275 11 7481 7491 10713051 1:CAS:528:DC%2BD3cXitVymu74%3D (Pubitemid 30159643)
123. I Mercier KG Bryant F Sotgia G Bonuccelli AK Witkiewicz A Dasgupta JF Jasmin RG Pestell MP Lisanti 2009 Using caveolin-1 epithelial immunostaining patterns to stratify human breast cancer patients and predict the caveolin-1 (P132L) mutation Cell Cycle 8 9 1396 1401 8307[pii] 19342880 1:CAS:528:DC%2BD1MXmvFCiurs%3D
124. G Bonuccelli MC Casimiro F Sotgia C Wang M Liu S Katiyar J Zhou E Dew F Capozza KM Daumer C Minetti JN Milliman F Alpy MC Rio C Tomasetto I Mercier N Flomenberg PG Frank RG Pestell MP Lisanti 2009 Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature Am J Pathol 174 5 1650 1662 ajpath.2009.080648[pii]10.2353/ajpath.2009.080648 19395651 1:CAS:528: DC%2BD1MXlvVWnu74%3D
125. S Pavlides D Whitaker-Menezes R Castello-Cros N Flomenberg AK Witkiewicz PG Frank MC Casimiro C Wang P Fortina S Addya RG Pestell UE Martinez-Outschoorn F Sotgia MP Lisanti 2009 The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma Cell Cycle 8 23 3984 4001 10238[pii] 19923890 1:CAS:528:DC%2BC3cXotlWrtbc%3D
126. I Mercier JF Jasmin S Pavlides C Minetti N Flomenberg RG Pestell PG Frank F Sotgia MP Lisanti 2009 Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders Lab Invest 89 6 614 623 labinvest200923[pii]10.1038/labinvest.2009.23 19333235 1:CAS:528:DC%2BD1MXmsVOrtbo%3D
127. LA Carver JE Schnitzer 2003 Caveolae: mining little caves for new cancer targets Nat Rev Cancer 3 8 571 581 10.1038/nrc1146nrc1146[pii] 12894245 1:CAS:528:DC%2BD3sXlvV2iu7s%3D (Pubitemid 37328829)
128. JP Gratton MI Lin J Yu ED Weiss ZL Jiang TA Fairchild Y Iwakiri R Groszmann KP Claffey YC Cheng WC Sessa 2003 Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice Cancer Cell 4 1 31 39 S1535610803001685[pii] 12892711 1:CAS:528:DC%2BD3sXmt1SltLs%3D (Pubitemid 36904159)
129. M Bucci JP Gratton RD Rudic L Acevedo F Roviezzo G Cirino WC Sessa 2000 In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation Nat Med 6 12 1362 1367 10.1038/82176 11100121 1:CAS:528:DC%2BD3cXosl2hs78%3D (Pubitemid 32001020)
130. C Cai J Chen 2004 Overexpression of caveolin-1 induces alteration of multidrug resistance in Hs578T breast adenocarcinoma cells Int J Cancer 111 4 522 529 10.1002/ijc.20300 15239129 1:CAS:528:DC%2BD2cXmsFeqtbs%3D (Pubitemid 39045318)
131. K Altundag N Bulut O Dizdar H Harputluoglu 2006 Albumin-bound paclitaxel, ABI-007 may show better efficacy than paclitaxel in basal-like breast cancers: association between caveolin-1 expression and ABI-007 Breast Cancer Res Treat 100 3 329 330 10.1007/s10549-006-9250-8 16897435 (Pubitemid 44707927)
132. WJ Gradishar S Tjulandin N Davidson H Shaw N Desai P Bhar M Hawkins J O'Shaughnessy 2005 Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer J Clin Oncol 23 31 7794 7803 JCO.2005.04.937[pii]10.1200/JCO.2005.04.937 16172456 1:CAS:528:DC%2BD2MXht1Cqs7nK (Pubitemid 46657376)
133. A Schlegel MP Lisanti 2000 A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo J Biol Chem 275 28 21605 21617 10.1074/jbc.M002558200M002558200[pii] 10801850 1:CAS:528:DC%2BD3cXkvFGisbg%3D (Pubitemid 30481867)
134. Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG, Lisanti MP (1998) Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 17(22):6633-6648 (Pubitemid 28521797)
135. Wu P, Wang X, Li F, Qi B, Zhu H, Liu S, Cui Y, Chen J (2008) Growth suppression of MCF-7 cancer cell-derived xenografts in nude mice by caveolin-1. Biochem Biophys Res Commun 376(1):215-220